Target Corporation logo

Target Corporation (TGT)

Market Open
8 Jun, 18:50
NYSE NYSE
$
123. 08
+0.51
+0.4161%
$
55.67B Market Cap
17.63 P/E Ratio
23.53% Div Yield
179,726 Volume
5.54 Eps
$ 122.57
Previous Close
Add Transaction
Day Range
120.8 124
Year Range
83.44 133.1
Want to track TGT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Target pushes shoplifting crackdown by telling employees to stop thefts worth at least $50

Target pushes shoplifting crackdown by telling employees to stop thefts worth at least $50

Target plans to crack down on retail theft by lowering the threshold for how much shoplifters can swipe before employees are allowed to finally step in.

Nypost | 1 year ago
I'm Not Going To Tell You What My Price Target Is On Micron

I'm Not Going To Tell You What My Price Target Is On Micron

Micron  MICR: Bad reaction to an ok earnings print. The print was not amazing, they beat respectable and guided inline.

Benzinga | 1 year ago
Goldman Sachs Raises Stock Target for Affirm: Key Insights

Goldman Sachs Raises Stock Target for Affirm: Key Insights

Despite what most market investors may believe, the new business model taking over the consumer discretionary sector and even the financial industry is here to stay much longer. Known as buy now, pay later (BNPL), this business model is precisely what today's consumer needs as the U.S. economy remains somewhat directionless.

Marketbeat | 1 year ago
Target (TGT) Gears Up for Target Circle Week, Promises Big Deals

Target (TGT) Gears Up for Target Circle Week, Promises Big Deals

Target's (TGT) Target Circle Week is not just a sales event but a strategic initiative aimed at bolstering customer engagement and loyalty.

Zacks | 1 year ago
Where Will You Shop This July: Target, Walmart or Amazon?

Where Will You Shop This July: Target, Walmart or Amazon?

July's retail landscape promises to be highly competitive, with Target (TGT), Walmart (WMT) and Amazon (AMZN) each deploying strategic initiatives to capture consumer dollars.

Zacks | 1 year ago
Target Gets a Shopify Boost

Target Gets a Shopify Boost

Shopify merchants are coming to Target.

Fool | 1 year ago
Target Seeks New Marketing Chief in Leadership Shakeup

Target Seeks New Marketing Chief in Leadership Shakeup

Target is seeking a new head of marketing amid a spate of leadership changes. The retail giant's current chief marketing officer, Lisa Roath, has been named Target's new chief merchandising officer for food, essentials and beauty, scheduled to take on that role early next year, the company announced Tuesday (June 25).

Pymnts | 1 year ago
Target Circle Week Returns in July, Competing With Amazon Prime Day

Target Circle Week Returns in July, Competing With Amazon Prime Day

One of Target's biggest sale events of the year, Target Circle Week, has just been announced to take place right before Amazon's Prime Day sale.

Cnet | 1 year ago
Target Gets a Marketplace and Shopify Merchants Get Distribution

Target Gets a Marketplace and Shopify Merchants Get Distribution

For Target, the most immediate impact adding Shopify sellers to its third-party marketplace may be a lift in its online fortunes. To that end, and as reported this week, Target will begin including select Shopify merchants on Target Plus, the retailer's third-party digital marketplace.

Pymnts | 1 year ago
Target (TGT) Partners With Shopify to Expand Target Plus Market

Target (TGT) Partners With Shopify to Expand Target Plus Market

Target (TGT) partners with Shopify to expand its Target Plus marketplace, introducing trendy, affordable products and bringing select Shopify items into Target's physical stores.

Zacks | 1 year ago
Target Stock Slips After Company Lowers More Prices

Target Stock Slips After Company Lowers More Prices

Bargain hunting is the order of the day, but price wars aren't good for retailers.

Barrons | 1 year ago
Will Elevidys Approval Make Sarepta Stock An Acquisition Target?

Will Elevidys Approval Make Sarepta Stock An Acquisition Target?

The stock price of Sarepta Therapeutics, a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases, was up 30% on Friday, June 21. This move came after the company secured the U.S. FDA approval for its Duchenne muscular dystrophy gene therapy – Elevidys – for all patients aged four and older.

Forbes | 1 year ago
Loading...
Load More